The Company develops and commercializes bio-active drug-device combination products for the healing of musculoskeletal injuries and diseases, including periodontal, orthopedic, spine and sports injury applications.
The best Bull and Bear pitches based on recency and number of recommendations.
9/18/11 Options Predictor Rank #42. P/C Ratio 0.098 and Call Sizzle 2.628.
June has been an atypically good month for a diverse basket of biotech stocks, and BioMimetic is one that leaves me scratching my head. BioMimetic was one of my many ill-advised 2011 investments which I finally shed at 3 earlier this year once I… More
Read the most recent pitches from players about BMTI.DL.
Find the members with the highest scoring picks in BMTI.DL.
See what the Wall Street professionals think, according to their public statements and filings.